Molecular and genetic aspects of preeclampsia: State of the art

Molecular Genetics and Metabolism

Volumn 71, Issue 4, 2000, Pages 565-572

  Tálosi, Gyula ^a   Endreffy, Emöke ^a   Túri, Sándor ^a   Németh, Ilona ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Angiotensinogen; Genetics; Human leukocyte antigens; Preeclampsia; Pregnancy

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; HLA ANTIGEN; NITRIC OXIDE SYNTHASE; RENIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; BLOOD CLOTTING DISORDER; DYSLIPIDEMIA; ECLAMPSIA; FEMALE; GENETIC VARIABILITY; GENOME; HELLP SYNDROME; HEREDITY; HUMAN; MORBIDITY; PATHOGENESIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SHORT SURVEY; TROPHOBLAST;

EID: 0034520568     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3099     Document Type: Article

References (82)

1. Genetics of pre-eclampsia
2. Syndrome of hemolysis, elevated liver enzymes and low platelet count: A severe consequence of hypertension in pregnancy
3. Fetal and maternal contributions to the risk of pre-eclampsia: Population-based study
4. A woman's own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease
5. Job stress and preeclampsia
6. Preeclampsia: What we know and what we do not know
7. Current topic: Pre-eclampsia and the placenta
8. Pre-eclampsia: More than pregnancy-induced hypertension
9. Experimental preeclampsia produced by chronic constriction of the lower aorta: Validation with longitudinal blood pressure measurements in conscious rhesus monkeys
10. The physiological response of the vessels of the placental bed to normal pregnancy
11. Utero-placental arterial changes related to interstitial trophoblast migration in early human pregnancy
12. Placental bed spiral arteries in the hypertensive disorders of pregnancy
13. The ultrastructural study of utero placental arteries in hypertensive and normotensive pregnancy and fetal growth retardation
14. Preeclampsia: An endothelial cell disorder
15. Hypoxia stimulates cytokine production by villous explants from the human placenta
16. Expression of placental cytokines, tumor necrosis factor-alpha and interleukin-1beta and interleukine 10 is increased in preeclampsia
17. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia
18. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
19. Increased frequency of genetic thrombophilia in women with complications of pregnancy
20. Preeclampsia and genetic risk factors for thrombosis: A case-control study
21. Methylenetetrahydrofolate reductase polymorphism and preeclampsia
22. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia
23. Analysis of thrombomodulin gene polymorphism in women with severe early-onset preeclampsia
24. Placental plasminogen activator activity in pre-eclampsia
25. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia
26. Hypothesis: Which plasma factors bring about disturbance of endothelial function in pre-eclampsia?
27. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia
28. Plasma lipids and vascular dysfunction in preeclampsia
29. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene
30. Oxidative stress in the pathogenesis of preeclampsia
31. The pathogenetic role of heme in pregnancy-induced hypertension-like disease in ewes
32. Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red blood cell turnover in preeclampsia
33. Hemin a possible physiological mediator of low density lipoprotein oxidation and endothelial injury
34. Hypothesis: Inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia
35. Free haemoglobin and pre-eclampsia
36. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia
37. Promoter mutation in the tumor necrosis factor alpha gene is not associated with preeclampsia
38. The familial factor in toxemia of pregnancy
39. Genetics of hypertension in pregnancy: Possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women
40. Analysis of different inheritance patterns in pre-eclampsia/eclampsia syndrome
41. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13
42. A genomewide linkage study of pre-eclampsia/eclampsia reveals evidence for a candidate region on 4q
43. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population
44. Pre-eclampsia - A mitochondrial disease?
45. Mutations in mitochondrial transfer ribonucleic acid genes in preeclampsia
46. Change of paternity: A risk factor for preeclampsia in multiparas
47. HLA antigens in severe pre-eclampsia
48. Human leucocyte antigens and mixed lymphocyte reactions in severe pre-eclampsia
49. Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DRβ
50. The immunology of pre-eclampsia
51. HLA and maternal-fetal recognition
52. A class I antigen, HLA G, expressed in human trophoblasts
53. Immunotolerant functions of HLA-G
54. HLA-G deletion polymorphism and pre-eclampsia/eclampsia
55. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia
56. Human spiral artery renin angiotensin system
57. The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy
58. The uteroplacental renin-angiotensin system: A review
59. Mead. Neovascularization produced by angiotensin II
60. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary, endothelial cells
61. Genetic analysis of the human type- 1 angiotensin receptor
62. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer
63. Angiotensin receptors in the human placenta are type AT1
64. Cellular localization of AT1 eceptor mRNA and protein in normal placenta and its reduced expression in growth restriction
65. Molecular basis of human hypertension: Role of angiotensinogen
66. A molecular variant of angiotensinogen associated with preeclampsia
67. Angiotensinogen T235 expression is elevated in decidual spiral arteries
68. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua
69. Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese
70. Is angiotensinogen gene polymorphism associated with hypertension in pregnancy?
71. Effect of angiotensin-converting enzyme activity and zinc concentration
72. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies
73. Renin gene restriction fragment length polymorphism do not show linkage with preeclampsia and eclampsia
74. Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia
75. Endothelial nitric oxide synthase in human placenta: Regional distribution and proposed regulatory role at the fetal-maternal interface
76. The action of nitric oxide in the perfused human fetal-placental circulation
77. Human trophoblast invasion and spiral artery transformation: The role of nitric oxide
78. Nitric oxide sythase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies
79. Reduction of placental nitric oxide synthase activity in pre-eclampsia
80. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region
81. Failure to detect linkage of preeclampsia to the region of the NOS3 locus on chromosome 7q
82. Genetic susceptibility to pre-eclampsia and chromosome 7q36